Article
Higher-order aberrations decreased in most patients, with the change from baseline reaching up to 50%.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
KAIST announces new microbe development for lutein production
3 Things You Should Know About Interventional Glaucoma Comanagement
New RainDrop Dispenser Aid aims to simplify use of single-use eye drops
Patient-Centered Treatment Strategies in the Management of nAMD and DME
MidWest Eye Center among first in Midwest to adopt new noncontact laser for glaucoma
Nanoscope Therapeutics initiates rolling submission of BLA to FDA for MCO-010